Safety Risks lead to withdrawal of AstraZeneca’s anti-cancer drug in India
New Delhi: The Drug Controller General of India (DCGI) has ordered the withdrawal of AstraZeneca's anti-cancer drug Olaparib tablets from ...
New Delhi: The Drug Controller General of India (DCGI) has ordered the withdrawal of AstraZeneca's anti-cancer drug Olaparib tablets from ...